Let's Get Started

News

Therma Bright Inc (TSXV:THRM) (OTCQB:TBRIF) Signs The Exclusive Worldwide Licensing Rights To Market And Sell Ai4lyf’s Digital Cough Technology (Dct)

Therma Bright Inc (TSXV:THRM) (OTCQB:TBRIF) Signs The Exclusive Worldwide Licensing Rights To Market And Sell Ai4lyf’s Digital Cough Technology (Dct)

Feb 16, 2023

The medical devices industry has grown at a decent clip over the course of the past years and one of the companies which could be worth looking into at this point is Therma Bright Inc (TSXV:THRM) (OTCQB:TBRIF). The company is currently best known for having developed the smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test but it has been working on other devices as well.

This morning the company has come into the news cycle after it announced that it had inked the exclusive global licensing rights to sell and market AI4LYF’s Digital Cough Technology (DCT). It was another major development for the company and one that is expected to bring Therma Bright onto the radars of investors.

The most important thing to point out with regard to DCT is the fact that the technology can help in detecting a range of respiratory diseases instantly and that includes COVID-19. The technology is deployed through a smartphone application and it can work anywhere at any time.

More importantly, the exclusive license is particularly important for Therma Bright. That would allow the company to work on the development of DCT solutions for detecting other diseases like bronchiolitis, asthma, and pneumonia among others.

It goes without saying that the latest development could well be a significant one for Therma Bright and investors could consider keeping an eye on the stock. Back in November 2022, it had been announced that the patent-pending DCT solutions was a revolutionary technology, powered by an artificial intelligence engine, which could change the way respiratory diseases were detected.

For instance, the app can come up with a result for the COVID-19 test within a minute and more importantly, it has managed to clock an accuracy rate of as much as 94%.

Small Cap Exclusive is owned and operated by King Tide Media, which is a US based corporation has been compensated $60,000 from Therma Bright Inc for profiling TBRIF for 30 days starting Feb 21 2023. We own ZERO shares in TBRIF.

read more
Lordstown Motors: RIDE Stock Gains Momentum: But Why?

Lordstown Motors: RIDE Stock Gains Momentum: But Why?

Feb 16, 2023

Electric vehicle manufacturing company Lordstown Motors Corp (NASDAQ:RIDE) is one of the companies to have come into sharp focus among investors in recent days and that can be gauged from the price action in the RIDE stock.

Over the course of the past week, the stock has managed to clock gains of 18% and that took the gains over the past month to as much as 25%. While it is currently trading above its key averages, it should not be forgotten that it is still down by 45% in the past six months.

Lordstown Motors Corp

Company Name: Lordstown Motors Corp

Ticker: RIDE

Exchange: NASDAQ

Website: https://www.lordstownmotors.com

Lordstown Motors Corp Summary:

Lordstown Motors Corp. develops, manufactures, and sells Endurance, an electric full-size pickup truck for fleet customers. The company was founded in 2019 and is based in Lordstown, Ohio.

Let’s take a look at the company’s recent news and developments of RIDE stock:-

#1 Expects Slow Rate Of Production in 1Q

The company had actually been in the news in recent times and came up with a key update back on January 4, 2023. At the time it announced that the rate of production in the first quarter was going to be slow owing to supply chain issues.

The company sent in a filing to the United States Securities and Exchange Commission in which it noted that the main supply chain problem was related to hub motor components availability. It was in the third quarter of 2022 that the company started the production of its Endurance pickup truck.

RIDE stock reacted positively after the news.

#2 Starts Shipping First Endurance Trucks To Customers

Last, in the month of January the company was in the news once again after it announced on January 11 that it had started shipping its first batch of Endurance pickup trucks to its customers.

At the time it was also announced by Lordstown Motors that the Endurance pickup truck had been named one of the three finalists in the North American Truck of the Year event for 2023.

#3 LEVs Market Projected To See a CAGR of 9.4%

While these are significant developments, it is perhaps most important for investors to keep in mind that Lordstown Motors is involved in an industry with the potential for significant growth. The light electric vehicle market is expected to have a valuation of $122.7 billion by 2027 from only $78.5 billion in 2022.

Keep an eye on RIDE stock as it is consolidating after the recent jump.

read more
Friday Feb 3rd, All eyes on MDJH our low float momentum play!

Friday Feb 3rd, All eyes on MDJH our low float momentum play!

Feb 2, 2023

Pull up MDJH now, super low float momentum play for Friday, tomorrow, Feb 3rd.

The float is super low at 1.4M shares!

This stock has a history of 100% gains with very low volume.

MDJH should be very active in the morning, so be ready!

The definition of a momentum play is:

when you buy a stock because the stock is moving big and you are hoping to scalp a quick gain if the move continues.

We think this is going to be “moving big” at the morning bell.

Remember, this stock moves very fast on a few trades.

So be ready tomorrow morning!

We have identified 2 catalysts revealing the hidden potential with MDJH.

Before we go over the catalysts, let’s do a quick summary on MDJM Ltd (NASDAQ: MDJH)

MDJM Ltd Company Summary

Company Name: MDJM Ltd

Ticker: MDJH

Exchange: NASDAQ

Website: http://ir.mdjmjh.com/

MDJM Ltd Growing Systems Company Summary:

Founded in 2002 and headquartered in Tianjin, China, Mingda Tianjin is an emerging, integrated real estate services company in China.

We primarily provide primary real estate agency services to our real estate developer clients, and provide, on an as-needed basis, real estate consulting services, and independent training services.

MDJM Ltd.

MDJH Has Two Catalysts That Could Send It To The Moon Tomorrow

#1 Low Float

#2 Small amount of volume makes it explode

MDJH

LOW supply & HIGH Demand = Massive PPS Increases, it’s simple math!

Stock MDJH has ONLY 1.4M shares in the float.

Our last two alerts traded 1M shares each, that would almost be the WHOLE FLOAT!

Our subscribers have an amazing opportunity!

What do we mean by, “our subscribers have an amazing opportunity!”?

We love low float stocks because of their ability to MOVE.

They provide great upside opportunities for day traders.

What is a “low float stock”?

Low float stocks are those with a low number of shares. Floating stock is calculated by subtracting closely-held shares and restricted stock from a firm’s total outstanding shares. Closely-held shares are those owned by insiders, major shareholders, and employees.

MDJH has only 1.4M shares in the float.

While the average NASDAQ float we normally feature is 10M shares, 10X higher!

This stock has very little supply of shares in the market and our subscribers normally create a large amount of demand.

Remember, LOW supply & HIGH Demand = Massive PPS Increases, it’s simple math!

Mdjh

MDJH

On August 2nd of last year MDJH traded around our average volume of 1.7M shares and went up almost 100%!

That day went like this, someone invested $10,000 and had $20,000 in just a few hours.

Again, our average alerts trade 1-2M shares

The last time MDJH had that kind of volume was in August and went up almost 100%!

Let’s Recap The Two Catalysts That Could Send It To The Moon Tomorrow

#1 Low Float

#2 Small amount of volume makes it explode

Disclaimer

Small Cap Exclusive is owned and operated by JBN PARTNERS LLC, which is a US based corporation has not been compensated for profiling MDJH. We own ZERO shares in MDJH.

Full Disclaimer

read more
FLGC Stock: Flora Growth (NASDAQ:FLGC) Gains Momentum On Revenue Growth: Will It Sustain?

FLGC Stock: Flora Growth (NASDAQ:FLGC) Gains Momentum On Revenue Growth: Will It Sustain?

Feb 2, 2023

A stock that has managed to come onto the surface following a strong move over the course of the past few days is FLGC stock. Flora Growth Corp (NASDAQ:FLGC), which is involved in the outdoor cultivation, manufacturing, and distribution of cannabis products, was in the news earlier on in the week.

Flora Growth Corp

Company Name: Flora Growth Corp

Ticker: FLGC

Exchange: NASDAQ

Website: https://www.floragrowth.com

Flora Growth Corp Summary:

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands designed to deliver the most compelling customer experiences in the world, one community at a time.

As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions.

Now, let’s analyze the latest news from FLGC stock:-

#1 Expects 100% Topline Growth For Fiscal 2023

On Monday the company announced that it expected its revenues for the fiscal year of 2023 to be in the $90 million to $105 million range. It was a significant new announcement from the company and on the day of the announcement the stock clocked gains of as much as 40%. In this regard, it should also be noted that a survey by FactSet expected the company to post revenues of $95.6 million for the year.

The company included the revenues that were projected from its new acquisition Franchise Global Health, a Germany-based business, in its projections.

FLGC stock reacted bullishly after the news.

#2 Gets Additional 180 Day Extension by Nasdaq to Regain Compliance

Earlier on in the month of January 2023, the company had come into the news once again after it announced that it had got an extension of 180 days from NASDAQ so as to fulfill the $1 minimum bid price requirement that is part of the listing rules of the exchange.

The initial period of 180 days to regain compliance expired back on January 4, 2023. The extension could be construed as a positive development for the company as it tries to stay listed on the exchange.

#3 Acquisition of Franchise Global Health

The acquisition of Franchise Global Health, which had been completed in December last year could well be a cornerstone for the company’s growth.

Thanks to the acquisition the company is going to establish a presence in the fast-growing German market and sell medical cannabis through more than 1200 pharmacies as well as distribution outlets spread across 28 nations. Franchise Global Health generated a gross profit of C$2.8 million and revenues of C$42 million in the nine-month period that ended on September 30, 2022.

After the recent rally, the stock might find resistance at a higher lever, and profit booking may be healthy for now.

Take a look at the CIFR stock, which is flying after a key update.

read more
OPEN Stock: Opendoor Technologies Inc (NASDAQ:OPEN) Bounces Back: Will It Continue?

OPEN Stock: Opendoor Technologies Inc (NASDAQ:OPEN) Bounces Back: Will It Continue?

Feb 1, 2023

Residential real estate transaction platform operator Opendoor Technologies Inc (NASDAQ:OPEN) is one of the more innovative companies at the moment and the OPEN stock has been in the middle of a strong ride in recent weeks. The stock has continued to climb in the past week during the course of which it went up by 38%.

That took the gains made in the past month to as much as 98% as the OPEN stock ended up hitting its highest level in many months.

Opendoor Technologies Inc

Company Name: Opendoor Technologies Inc

Ticker: OPEN

Exchange: NASDAQ

Website: https://www.opendoor.com

Opendoor Technologies Inc Summary:

Opendoor Technologies Inc. operates a digital platform for residential real estate in the United States. The company’s platform enables consumers to buy and sell a home online. It also provides title insurance and escrow services. Opendoor Technologies Inc. was incorporated in 2013 and is based in Tempe, Arizona.

Now, let’s review the latest news from the company:-

#1 Q4 Earnings On Radar – All eyes on OPEN stock

All eyes are now going to be on the company’s fourth-quarter financial results and it may be a good time to keep an eye on the Opendoor stock in the lead-up to the day.

On January 26 the company announced that it was going to announce its financial results for the fourth fiscal quarter that ended on December 31, 2022, on February 23, 2023. On top of that, the management would also host a conference call to discuss the financial results and other operations. The conference call would be available on a live webcast at 2 pm PT.

It would be keenly watched, how the OPEN stock would react after earnings.

#2 Opendoor Shuffles Leadership, Appoints New CEO

The performance in the third quarter of Opendoor may have triggered a change in the management as well and back on December 2, 2022, the company made such an announcement. It announced that it had appointed a new Chief Executive Officer in the form of Carrie Wheeler.

Wheeler had previously been the Chief Financial Officer at Opendoor. The shakeup at the top echelons in the management had initially led to a selloff in the stock. Wheeler was also made a member of the board of directors of the company with immediate effect.

#3 Why The OPEN stock Fell Last Year

Last year, the stock had gone through a tough time as the weakness in demand and plunging home prices took their toll. In the third quarter, the company’s performance had been disappointing and that resulted in a 20% drop in the stock price. That took the cumulative loss in a 12-month period to 88%.

Keep an eye on OPEN stock and it would be interesting to see if the stock reverses its losses from the last year.

read more
TCBP Stock: TC BioPharm (NASDAQ:TCBP) Stock On Radar Ahead of A Key Event

TCBP Stock: TC BioPharm (NASDAQ:TCBP) Stock On Radar Ahead of A Key Event

Jan 31, 2023

Clinical-stage biotech company TC BioPharm (NASDAQ:TCBP) has seen it’s stock considerable momentum over the course of the past month and it could well be a good time to start taking a deeper look into it. In the past week, TCBP stock clocked gains of 13% and that took the gains made by it over the course of the past month to as much as 40%.

The company is mainly involved in the development of platform allogeneic gamma-delta T cell therapies which are meant for treating cancer.

TC BioPharm

Company Name: TC BioPharm

Ticker: TCBP

Exchange: NASDAQ

Website: https://www.tcbiopharm.com/

Adamas One Corp Summary:

TC BioPharm is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer with human efficacy data in acute myeloid leukemia. Gamma-delta T cells are naturally occurring immune cells that embody properties of both the innate and adaptive immune systems and can intrinsically differentiate between healthy and diseased tissue. TC BioPharm uses an allogeneic approach in both unmodified and CAR modified gamma-delta T cells to effectively identify, target and eradicate both liquid and solid tumors in cancer.

Here are the latest news from TCBP stock:-

#1 All Eyes On Shareholder Update Call

The company was in the news last week on January 20 when it announced that it was going to come up with a shareholder update on February 20, 2023, at 10 in the morning Eastern Standard Time.

In that particular update, the management of TC BioPharm would be looking to provide a detailed update with regard to the trial plan for the allogeneic gamma delta therapeutic in different oncology indications. There will also be a question and answer session after CFO Martin Thorp and CEO Bryan Kobel complete their remarks.

It would be interesting to see how would TCBP stock react after the event.

#2 Receives Notice of Non-compliance with NASDAQ’s Listing Rule 5550(b)(1)

On January 19, it emerged that TC BioPharm had been provided with a written notification from NASDAQ with regards to the fact that it had failed to regain compliance as per the minimum Market Value of Listed Securities threshold of $35,000,000. That figure is the minimum for continued listing on the exchange.

The company announced at the time that it was going to present the exchange with a comprehensive plan on how it was going to address the situation and regain compliance.

#3 Strategic Collaboration to Advance Gamma Delta T Cells in Oncology

Another major development with regards to TC BioPharm was the announcement from the company earlier this month on January 17 that it had decided to get into collaboration with the celebrated University of Texas MD Anderson Cancer Center.

The collaboration would be focussed on expanding the knowledge with regard to the deployment of gamma-delta T cells in oncology. It remains to be seen if TCBP stock can hold onto its momentum this week.

So, keep an eye on TCBP stock as shareholders would reach to the company’s upcoming earnings and we may see high volatility. Get more lists of stocks here

read more
JEWL Stock: Adamas One Corp (NASDAQ:JEWL) On Watchlist After Recent Fall

JEWL Stock: Adamas One Corp (NASDAQ:JEWL) On Watchlist After Recent Fall

Jan 27, 2023

Technology has influenced most industries in the world in a big way and in this regard, even the jewelry industry is no exception. In this context, it may be a good time for JEWL stock investors to look into Adamas One Corp (NASDAQ:JEWL), which has emerged as one of the more innovative companies in the industry.

The company has managed to leverage technology to create lab-created diamonds, which can be used both for making jewelry and also for industrial purposes.

Adamas One Corp

Company Name: Adamas One Corp

Ticker: JEWL

Exchange: NASDAQ

Website: https://www.adamasone.com

Adamas One Corp Summary:

Adamas One Corp., a diamond company, produces single crystal diamonds and diamond materials for diamond jewelry industry and industrial markets in the United States and internationally. The company was incorporated in 2018 and is based in Scottsdale, Arizona.

Here are the latest news from JEWL stock:-

 #1 Influencer TRAX NYC Visits Adamas One South Carolina Factory

Last week on January 19, the company was in the news after it announced that TRAX NYC, a jewellery influence had gone on a video tour of its facility in Greenville, South Carolina, and posted a video on Instagram.

The video had proven to be a roaring success and within the first hour it had clocked as many as 200,000 views. Such a video could often prove to be a potent marketing campaign in the age of social media and it could only be seen as a positive for Adamas One.

JEWL stock reacted muted to the news.

#2 Reports Initial Diamond Sales for Fiscal Year 2022

On January 18, the company came into the news cycle once again when it announced its financial results for the fiscal year that ended on September 30, 2022. The company noted that during that financial year, it had managed to sell as much as $1.78 million worth of its lab-grown diamonds.

That was a major turnaround considering the fact that in the previous fiscal year, the total sales had stood at $0.

#3 Newly Lists Stock – Forms Base After Recent Fall

The company started its marketing campaign in the middle of the second quarter and hence, most of the sales was closed in the final seven months of the fiscal year. That came as a significant boost as well considering the fact that Adamas One was listed on the JEWL stock market back on December 16, 2022, in an initial public offering worth $11 million.

read more
NMRD Stock: Why is Nemaura Medical (NASDAQ: NMRD) A Top Stock To Watch in February?

NMRD Stock: Why is Nemaura Medical (NASDAQ: NMRD) A Top Stock To Watch in February?

Jan 26, 2023

Over the past week, the Nemaura Medical Inc (NASDAQ: NMRD) stock has been in the middle of a solid rally and recorded gains of 56% to emerging as one of the stock to watch. As it happens, the NMRD stock hit its highest level since mid-October last year.

Nemaura Medical Inc

Company Name: Nemaura Medical Inc

Ticker: NMRD

Exchange: NASDAQ

Website: https://nemauramedical.com

Nemaura Medical Inc Summary:

Nemaura Medical Inc. is a medical technology company developing and commercialising non-invasive wearable diagnostic devices. The Company is currently also commercialising sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, as a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse, and prevent the onset of diabetes.

There are certain specific triggers that led to the remarkable rally in the NMRD stock.

#1 Medical’s Program Shows Weight Loss In 100% Of Participants

One of those came about earlier in the week on January 24 when the company announced the initial results from the patient studies that had been conducted with the National Health Service (NHS) of the United Kingdom for Miboko, its metabolic health program.

The results were positive as the patients recorded an average weight loss of 3.7 pounds and all the patients experienced some degree of weight improvement.

This news had a major positive impact on NMRD stock and is one of the top stock to watch.

#2 Commences Pilot Program of Miboko with the NHS

While that was quite clearly a significant development it should be noted that the announcement with regards to the study for Miboko in collaboration with the NHS had been announced back on November 29, 2022.

Mikobo is the first product in its category to have a non-invasive glucose sensor in a lifestyle app. It not includes information with regard to drinking and good intake but also provides analytics and educational content. At the end of the analysis, the app provides the user with a metabolic score based on diet and other important factors.

#3 Solid Industry Growth

Nemaura is entering the Continuous Glucose Monitoring Market with the product and it is a market that is expanding rapidly. The market was worth as much as $6.13 billion back in 2021 and by 2030 it is expected to command a valuation of $16.33 billion, which reflects a CAGR of 17.33%.

So, considering the latest news and big jump, NMRD stock is one of the other top stock to watch for the month of February.

read more
A2Z Smart Technologies (NASDAQ:AZ) Is The Stock to Watch Following Multiple News

A2Z Smart Technologies (NASDAQ:AZ) Is The Stock to Watch Following Multiple News

Jan 25, 2023

At this point in time, investors are hotly on the trail of A2Z Smart Technologies Corp (NASDAQ:AZ) and that becomes apparent when one looks into the price action in the stock and is the notable stock to watch. Over the course of the past week alone, AZ stock has clocked gains of 43% and that took the gains over the past month to as much as 92%.

Why Such a Big Jump?

AZ stock has been witnessing continuous buying after announcing multiple news. Firstly, the stock reached a key partnership with Lenovo Group Limited. Secondly, the company announced a launch of a new Smart Cart model.

A2Z Smart Technologies Corp

Company Name: A2Z Smart Technologies Corp

Ticker: AZ

Exchange: NASDAQ

Website: https://a2zas.com/

A2Z Smart Technologies Corp Summary:

A2Z Smart Technologies Corp. creates innovative solutions for complex challenges. A2Z’s flagship product is an advanced proven-in-use mobile self-checkout shopping cart.

With its user-friendly smart algorithm, touch screen, and computer-vision system, Cust2Mate streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply “pick & go”, and bypass long cashier checkout lines. This results in a more efficient shopping experience for customers, less unused shelf-space and manpower requirements, and advanced command and control capabilities for store managers.

As AZ stock has soared over the past month, let’s analyze the key catalysts:-

#1 Big Partnership With Lenovo Group

Last Friday, the company announced that its subsidiary has partnered with Lenovo Group Limited. As per the joint venture, A2Z Smart Technologies will use Lenovo solutions in its revolutionary Cust2mate Smart Cart solution and Lenovo will actively sell and promote the solution through its extensive worldwide channels.

Hila Kraus, Head of Sales stated, “The Cust2Mate platform with embedded Lenovo OEM solution is designed to serve shoppers from the moment they enter the store until they leave-without any friction, lines, or delays.”

#2 Launches Next Generation V2.8 Light Smart Cart

AZ stock hit its 4-month high recently as a key contender for the stock to watch this year. One of the major catalysts behind the latest rally in the stock came about earlier this week when the company announced that it had launched its latest Smart Card model. The product in question is expected to further enhance the current range of offerings from A2Z Smart.

The company announced that the latest version of the model had been created after consulting with some of the major retail companies in the world from the Asian and European markets.

#3 It Will Display Its Smart Cart Line of Products at the NRF 2023 Big Retail Show In NYC

Moreover, earlier on in the month on January 12, the company made another announcement that had come as a positive trigger for the A2Z Smart stock. It announced that it was going to be one of the participants in the NRF Big Retail Show. The company announced at the time that it was going to display its Smart Cart Line at the event.

Considering the recent multiple news, AZ stock should be on your radar as a stock to watch in 2023.

read more